CLNN

Clene Inc.

Price

$3.47

return (12m)

-59.69%

p/e

-1.22

p/bv

-1.94

DIVIDEND YIELD

0.00%

CLNN price

Clene

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CLNN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

-44.11%

1 year

-59.69%

2 years

-37.79%

5 years

-97.28%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals CLNN

Valuation

P/E

-1.22

Sector -3.34

Industry -3.34

P/BV

-1.94

Sector 1.89

Industry 1.89

P/Revenue (PSR)

244.20

Sector 2.04

Industry 2.04

EV/EBITDA

-4.15

Sector -219.22

Industry -219.22

EV/EBIT

-4.04

Sector -47.87

Industry -47.87

P/EBITDA

-1.37

Sector -22.33

Industry -22.33

P/EBIT

-1.31

Sector -28.88

Industry -28.88

P/Total Assets

2.09

Sector 1.11

Industry 1.11

P/Net Current Assets

-1.46

Sector -9.46

Industry -9.46

P/Working Capital

4.78

Sector -148.60

Industry -148.60

EPS

-3.19

Sector -1.78

Industry -1.78

BVPS

-2.00

Sector 1.98

Industry 1.98

Efficiency

Gross Margin

70.05%

Sector 41.35%

Industry 41.35%

EBITDA Margin

-13,751.11%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

-100.00%

Sector -35.47%

Industry -35.47%

Net Profit Margins

-100.00%

Sector -35.90%

Industry -35.90%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

159.49%

Sector -57.36%

Industry -57.36%

ROA

-171.51%

Sector -59.44%

Industry -59.44%

ROIC

-160.32%

Sector -2,371.18%

Industry -2,371.18%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.07

Sector 2.91

Industry 2.91

Net Debt / EBITDA

-0.26

Sector -21.45

Industry -21.45

Net Debt / EBIT

-0.26

Sector -8.32

Industry -8.32

Net Debt / Equity

-0.13

Sector -33,201.77

Industry -33,201.77

Gross Debt / Equity

-0.52

Sector -0.85

Industry -0.85

Equity/Assets

-1.08

Sector 0.46

Industry 0.46

Liabilities/Assets

2.08

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-22.90%

Sector -

Industry -

5Y Earnings CAGR

32.33%

Sector -

Industry -

Fundamentals CLNN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CLNN Clene Inc.	$3.47	-59.69%	0.00%	-1.22	-1.94	159.49%	-100.00%
PFE Pfizer Inc.	$28.25	23.91%	6.23%	36.34	1.84	5.07%	6.80%
ABBV AbbVie Inc.	$276.61	23.83%	2.47%	77.50	-82.49	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.20	-30.25%	4.83%	9.39	4.99	53.11%	35.32%
MRK Merck & Co. Inc.	$142.71	70.83%	2.34%	113.15	8.55	7.56%	4.77%
AZN AstraZeneca PLC	$157.00	-5.51%	2.03%	19.02	4.90	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$56.36	35.67%	4.26%	12.97	5.39	41.59%	18.87%
ZTS Zoetis Inc.	$75.14	-45.73%	2.81%	11.76	9.85	83.77%	27.69%
AMGN Amgen Inc.	$414.70	46.88%	2.41%	25.51	19.08	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$750.47	35.09%	0.49%	17.80	2.43	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$109.37	70.62%	0.00%	31.72	91.40	288.13%	24.86%
MCK McKesson Corporation	$962.85	26.60%	0.36%	24.20	-28.76	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$489.96	20.15%	0.00%	29.37	6.39	21.76%	35.00%
CAH Cardinal Health Inc.	$237.45	53.30%	0.86%	32.46	-20.43	-62.92%	0.67%
ARGX argenx SE	$803.12	0.78%	0.00%	15.66	4.13	26.35%	25.62%
HRMY Harmony Biosciences Holdings Inc.	$36.74	38.43%	0.00%	12.88	2.34	18.14%	18.88%
BIIB Biogen Inc.	$228.84	56.13%	0.00%	40.08	1.77	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CLNN - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Clene

Clene Inc.

Average Investor10 user rating

4.0 (0 people)

United States

13 years

Founded: 2013

2020

Time since IPO - 6 years

76

Employees

Clene Inc. (United States) is listed on the Nasdaq and has a market capitalization of $48.11 million, with shareholders equity totaling $-24.78 million.

The company employs approximately 76 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Clene Inc. reported $197.00 Thousand in revenue, generating net income of $-39.52 million.

Key financial metrics include a P/E ratio of -1.22, a price-to-book (P/B) ratio of -1.94, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CLNN.

Market cap

$48.11 million

Net worth

$-24.78 million

$-24,777,000.00

Assets

$23.04 million

$23,041,000.00

Total Shares Outstanding

12.38 million

12,382,000

Average Daily Trading Volume

$109.21 Thousand

$109,208.70

Sector

Health Care

Industry

Biotechnology

CLNN

CLNN revenue and profits

Financial Results CLNN

DRAG THE FRAME TO SEE MORE DATA

CLNN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$962.85 25,62% (12M)

P/E

24.20

0.36%

ROE

-118.84%

P/BV

-28.76

CAH - Cardinal Health

$237.45 55,85% (12M)

P/E

32.46

0.86%

ROE

-62.92%

P/BV

-20.43

ABBV - AbbVie

$276.61 23,94% (12M)

P/E

77.50

2.47%

ROE

-106.44%

P/BV

-82.49

MRK - Merck & Co.

$142.71 71,41% (12M)

P/E

113.15

2.34%

ROE

7.56%

P/BV

8.55

AZN - AstraZeneca

$157.00 --6,19% (12M)

P/E

19.02

2.03%

ROE

25.77%

P/BV

4.90

PFE - Pfizer

$28.25 24,16% (12M)

P/E

36.34

6.23%

ROE

5.07%

P/BV

1.84

BMY - Bristol-Myers Squibb

$56.36 36,98% (12M)

P/E

12.97

4.26%

ROE

41.59%

P/BV

5.39

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$962.85 25,62% (12 M)

P/L

24.20

0.36%

ROE

-118.84%

P/VP

-28.76

CAH - Cardinal Health

$237.45 55,85% (12 M)

P/L

32.46

0.86%

ROE

-62.92%

P/VP

-20.43

ABBV - AbbVie

$276.61 23,94% (12 M)

P/L

77.50

2.47%

ROE

-106.44%

P/VP

-82.49

MRK - Merck & Co.

$142.71 71,41% (12 M)

P/L

113.15

2.34%

ROE

7.56%

P/VP

8.55

AZN - AstraZeneca

$157.00 --6,19% (12 M)

P/L

19.02

2.03%

ROE

25.77%

P/VP

4.90

PFE - Pfizer

$28.25 24,16% (12 M)

P/L

36.34

6.23%

ROE

5.07%

P/VP

1.84

BMY - Bristol-Myers Squibb

$56.36 36,98% (12 M)

P/L

12.97

4.26%

ROE

41.59%

P/VP

5.39

Frequently Asked Questions

What is the price of Clene (CLNN) today?

The current price of Clene (CLNN) is $3.47. The stock began the year trading around $5.87 and is currently priced at $3.47. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Clene (CLNN) pay dividends?

Clene (CLNN) did not pay dividends over the past year.

Is Clene (CLNN) a good investment?

Clene (CLNN) is currently trading at $3.47 with a P/E ratio of -1.22. This represents a -98% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -59.69%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Clene (CLNN) stock?

You can buy Clene (CLNN) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol CLNN and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Clene (CLNN) yield today?

Over the past month, Clene (CLNN) has returned 0.00% — -59.69% over the past year, and -97.28% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Clene (CLNN) today at the current price of $3.47 your total investment would be $346.50.

Based on historical performance, the investment would have grown to approximately:

$139.67 after 1 year
$9.42 after 5 years
$346.50 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CLNN

Clene Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CLNN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING CLNN WITH OTHER STOCK

ABOUT Clene

Clene Inc.

United States

13 years

2020

76

PROFIT X PRICE CLNN

Financial Results CLNN

CLNN cash flow

Asset, Revenue and Profit Growth - CLNN

CLNN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions